{
    "root": "7909ce18-1906-4d64-b330-81c1c4c5ec88",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "DICLOFENAC SODIUM",
    "value": "20250317",
    "ingredients": [
        {
            "name": "diclofenac sodium",
            "code": "QTG126297Q"
        },
        {
            "name": "water",
            "code": "059QF0KO0R"
        },
        {
            "name": "benzyl alcohol",
            "code": "LKG8494WBH"
        },
        {
            "name": "hyaluronate sodium",
            "code": "YSE9PPT4TH"
        },
        {
            "name": "PEG-6 METHYL ETHER",
            "code": "WXH089JZ5E"
        }
    ],
    "indications": "diclofenac sodium gel indicated topical treatment actinic keratoses ( ak ) .",
    "contraindications": "lowest effective shortest duration consistent individual patient treatment goals [ ( 5 ) ] . apply diclofenac sodium gel gently lesion areas twice daily . adequately cover lesion . 0.5 g gel ( pea size ) 5 cm x 5 cm lesion site . recommended duration therapy 60 days 90 days . complete healing lesion ( ) optimal therapeutic effect may evident 30 days following cessation therapy . lesions respond therapy re-evaluated management reconsidered . avoid contact diclofenac sodium gel eyes mucous membranes .",
    "warningsAndPrecautions": "gram diclofenac sodium topical gel , 3 % contains 30 mg diclofenac sodium , usp . diclofenac sodium gel , 3 % available follows : ndc 68788-9435-1 100 g tube ( 1 tube per carton ) storage : store 20°c 25°c ( 68°f 77°f ) ; excursions permitted 15°c 30°c ( 59°f 86°f ) [ usp controlled room temperature ] . protect heat . avoid freezing .",
    "adverseReactions": "diclofenac sodium gel contraindicated following patients : •with known hypersensitivity ( e.g . , anaphylactic serious skin ) diclofenac components product [ ( 5.1,5.3 , 5.10 ) description ( 11 ) ] •with history asthma , urticaria , allergic type taking aspirin nsaids . severe , sometimes fatal , anaphylactic nsaids reported patients [ ( 5.1 , 5.2 ) ] •application damaged skin resulting etiology , including exudative dermatitis , eczema , infected lesions , burns wounds [ ( 5.3 ) ] •in setting coronary bypass graft ( cabg ) surgery [ ( 5.4 ) ]",
    "indications_original": "Diclofenac sodium gel is indicated for the topical treatment of actinic keratoses (AK).",
    "contraindications_original": "Use the lowest effective dosage for the shortest duration consistent with individual patient treatment goals [see Warnings and Precautions (5)].\n                  Apply diclofenac sodium gel gently to lesion areas twice daily. to adequately cover each lesion. Use 0.5 g of gel (pea size) on each 5 cm x 5 cm lesion site. The recommended duration of therapy is from 60 days to 90 days. Complete healing of the lesion(s) or optimal therapeutic effect may not be evident for up to 30 days following cessation of therapy. Lesions that do not respond to therapy should be re-evaluated and management reconsidered. Avoid contact of diclofenac sodium gel with eyes and mucous membranes.",
    "warningsAndPrecautions_original": "Each gram of Diclofenac Sodium Topical Gel, 3% contains 30 mg of diclofenac sodium, USP. Diclofenac Sodium Gel, 3% is available as follows:\n                  \n                     \n                         NDC 68788-9435-1\t100 g tube (1 tube per carton)\n                  \n                  \n                     Storage: Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Protect from heat. Avoid freezing.",
    "adverseReactions_original": "Diclofenac sodium gel is contraindicated in the following patients:\n                  \n                     \n                        •With known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to diclofenac or any components of the drug product [see Warnings and Precautions (5.1,5.3, 5.10) and Description (11)]\n                     \n                     \n                        •With the history of asthma, urticaria, or other allergic type reactions after taking aspirin or other NSAIDs. Severe, sometimes fatal, anaphylactic reactions to NSAIDs have been reported in such patients [see Warnings and Precautions (5.1, 5.2)]\n                     \n                     \n                        •Application on damaged skin resulting from any etiology, including exudative dermatitis, eczema, infected lesions, burns or wounds [see Warnings and Precautions (5.3)]\n                     \n                     \n                        •In the setting of coronary bypass graft (CABG) surgery [see Warnings and Precautions (5.4)]"
}